PerspectiveCancer

RNAi Therapies: Drugging the Undruggable

See allHide authors and affiliations

Science Translational Medicine  11 Jun 2014:
Vol. 6, Issue 240, pp. 240ps7
DOI: 10.1126/scitranslmed.3008362

Article Information

vol. 6 no. 240 240ps7

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • .

Author Information

  1. Sherry Y. Wu1,
  2. Gabriel Lopez-Berestein2,3,
  3. George A. Calin2,3 and
  4. Anil K. Sood1,3,4,*
  1. 1Departments of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA.
  2. 2Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA.
  3. 3Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA.
  4. 4Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA.
  1. *Corresponding author. E-mail: asood{at}mdanderson.org

Altmetric

Article usage

Article usage: June 2014 to November 2019

AbstractFullPdf
Jun 20146317425639
Jul 201487579164
Aug 20143972751
Sep 201453162107
Oct 20145476590
Nov 20144025358
Dec 20144864751
Jan 201572411298
Feb 20153413138
Mar 20154394389
Apr 20153875453
May 20153183118
Jun 20152261930
Jul 20151421227
Aug 20152082026
Sep 20153273140
Oct 20152153721
Nov 20151931838
Dec 20151541332
Jan 2016171924
Feb 20161422315
Mar 20162072546
Apr 20162113235
May 20161281216
Jun 20161471716
Jul 2016126910
Aug 2016105715
Sep 20161021015
Oct 2016105516
Nov 2016901413
Dec 201610489
Jan 201794816
Feb 20171101113
Mar 2017951826
Apr 20171421214
May 20171021426
Jun 20177678
Jul 20176370
Aug 2017891510
Sep 201790138
Oct 20171021419
Nov 201791108
Dec 20171131011
Jan 201885512
Feb 2018861831
Mar 2018891114
Apr 20181362317
May 201893310
Jun 20187457
Jul 20187753
Aug 201891124
Sep 201879116
Oct 201870126
Nov 201882229
Dec 201874137
Jan 20199148
Feb 2019631418
Mar 2019592213
Apr 2019892821
May 2019931410
Jun 201946107
Jul 20195374
Aug 20193599
Sep 20192977
Oct 201955166
Nov 20193066